Provided by Tiger Trade Technology Pte. Ltd.

Tandem Diabetes Care

22.32
-0.2500-1.11%
Volume:1.64M
Turnover:36.92M
Market Cap:1.55B
PE:-24.07
High:23.25
Open:23.25
Low:22.06
Close:22.57
52wk High:29.65
52wk Low:11.46
Shares:69.58M
Float Shares:63.59M
Volume Ratio:0.89
T/O Rate:2.57%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9274
EPS(LYR):-3.0424
ROE:-48.03%
ROA:-2.65%
PB:11.91
PE(LYR):-7.34

Loading ...

Tandem Diabetes initiated with an Outperform at William Blair

TIPRANKS
·
Aug 21

How Tandem’s Q2 Loss and Pharmacy Pivot Will Impact Tandem Diabetes Care (TNDM) Investors

Simply Wall St.
·
Aug 20

Tandem Diabetes price target raised to $24 from $21 at Citi

TIPRANKS
·
Aug 17

Citi Sticks to Its Hold Rating for Tandem Diabetes Care (TNDM)

TIPRANKS
·
Aug 14

Tandem Diabetes Care: Buy Rating Reaffirmed on Transformation Momentum and Innovation Catalysts; $40 Price Target Maintained

TIPRANKS
·
Aug 12

Tandem Diabetes Care Price Target Raised to $21.00/Share from $17.00 by Citigroup

Dow Jones
·
Aug 08

Tandem Diabetes Care's Underlying Q2 Trends Better Than Headline Suggests, RBC Says

MT Newswires Live
·
Aug 08

Stifel Nicolaus Reaffirms Their Hold Rating on Tandem Diabetes Care (TNDM)

TIPRANKS
·
Aug 08

RBC Adjusts PT on Tandem Diabetes Care to $26 From $30, Maintains Outperform Rating

MT Newswires Live
·
Aug 07

Tandem Diabetes price target raised to $40 from $35 at Canaccord

TIPRANKS
·
Aug 07

Tandem Diabetes Care, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 07

Tandem Diabetes Care Q2 EPS $(0.31) Beats $(0.32) Estimate, Sales $254.560M Miss $254.978M Estimate

Benzinga Earnings
·
Aug 07

Tandem Diabetes Care Q2 Net Income USD -21.2 Million

Reuters
·
Aug 07

Tandem Diabetes Care Q2 EPS USD -0.31

THOMSON REUTERS
·
Aug 07

DexCom Glucose Monitors' National Coverage Could Support H2 Upside, RBC Capital Markets Says

MT Newswires Live
·
Jul 31

Tandem Diabetes Care to Present Company Update at Canaccord Genuity Annual Growth Conference

Reuters
·
Jul 29

Tandem Diabetes Care Coverage Assumed by UBS at Neutral

Dow Jones
·
Jul 29

UBS Adjusts Price Target on Tandem Diabetes Care to $18 From $22, Maintains Neutral Rating

MT Newswires Live
·
Jul 28

Tandem Diabetes resumed with a Neutral at UBS

TIPRANKS
·
Jul 28

Tandem Diabetes Care (TNDM) Could Be 41% Undervalued As Pharmacy Expansion Lifts The Narrative

Simply Wall St.
·
Jul 28